Connor, Clark & Lunn Investment Management (CC&L)
AKRO icon

Connor, Clark & Lunn Investment Management (CC&L)’s Akero Therapeutics AKRO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.21M Buy
2024
Q4 		– Sell
2024
Q3 		$291K Sell
2024
Q2 		$1.64M Sell
2024
Q1 		$2.59M Buy
2023
Q4 		$234K Sell
2023
Q3 		$914K Sell
2023
Q2 		$1.11M Buy
2022
Q4 		– Sell
2022
Q3 		$2.39M Buy
2022
Q2 		$294K Buy